Ticker

Key Highlights   No material change:  There is no material change in the business affairs of Ocumetics.

Key Highlights   Early First-in-Human clinical results have drawn the attention of industry leaders and several of the largest vision care technology companies in the world.

Key Highlights   Breakthrough Accommodating Interocular Lens Design: The enhanced lens design introduces several novel concepts that are expected to improve substantially upon the consistency, durability, and manufacturability of the lens.

Calgary, Alberta – March 13, 2026 – TheNewswire -  Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) (the “ Corporation ”) announces that it has issued 500,000 incentive stock options to Howard Group Inc. “(Howard Group”), the Corporation's investor relations communications advisor, as required by the agreement between the Corporation and Howard Group announced on September 12, 2025.     Each option…

Calgary, Alberta – TheNewswire - February 26, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology, today announced the formation of a Scientific Advisory Committee (SAC) to support the Company's advancing clinical, regulatory, and commercialization strategy as it progresses toward late-stage development. The SAC…